Nishikii Hidekazu, Kurita Naoki, Shinagawa Atsushi, Sakamoto Tatsuhiro, Kusakabe Manabu, Yokoyama Yasuhisa, Kato Takayasu, Sakata-Yanagimoto Mamiko, Obara Naoshi, Hasegawa Yuichi, Nakamura Naoya, Chiba Shigeru
Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Department of Hemato-Oncology, Hitachi General Hospital, Hitachi, Japan.
Case Rep Hematol. 2019 Jan 3;2019:9710790. doi: 10.1155/2019/9710790. eCollection 2019.
A 38-year-old woman with aggressive clinical course of chronic lymphocytic leukemia (CLL) was treated with 8 courses of R-CHOP. Clinical remission was achieved, while B-cell clonality remained. Allogeneic hematopoietic stem cell transplantation was performed with reduced intensity conditioning (fludarabine and 2-Gy total body irradiation). However, autologous hematopoietic recovery occurred within a month after the transplant. Nevertheless, B-cell clonality became undetectable at 14 days after transplant, which has been kept so for over 10 years with clinical remission. Cytogenetic analyses were repeatedly performed and demonstrated nonclonal chromosomal aberrations, although the patient did not develop any secondary malignancies. One possible explanation for the clinical course is a very short-term allogeneic immune reaction helping eradication of residual CLL cells.
一名患有侵袭性慢性淋巴细胞白血病(CLL)病程的38岁女性接受了8个疗程的R-CHOP治疗。实现了临床缓解,但B细胞克隆性仍然存在。采用减低剂量预处理(氟达拉滨和2戈瑞全身照射)进行了异基因造血干细胞移植。然而,移植后一个月内出现了自体造血恢复。尽管如此,移植后14天B细胞克隆性变得无法检测到,并且在临床缓解的情况下一直保持了10多年。反复进行细胞遗传学分析,结果显示为非克隆性染色体畸变,尽管该患者未发生任何继发性恶性肿瘤。对于该临床病程,一种可能的解释是非常短期的异基因免疫反应有助于清除残留的CLL细胞。